Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer's Disease

Stock Information for Neurotrope Inc.

Loading

Please wait while we load your information from QuoteMedia.